Cargando…
CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells
The androgen receptor (AR) is a ligand-dependent transcription factor that promotes prostate cancer (PC) cell growth through control of target gene expression. This report suggests that Canopy FGF signaling regulator 2 (CNPY2) controls AR protein levels in PC cells. We found that AR was ubiquitinate...
Autores principales: | Ito, Saya, Ueno, Akihisa, Ueda, Takashi, Nakagawa, Hideo, Taniguchi, Hidefumi, Kayukawa, Naruhiro, Fujihara-Iwata, Atsuko, Hongo, Fumiya, Okihara, Koji, Ukimura, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915145/ https://www.ncbi.nlm.nih.gov/pubmed/29707137 http://dx.doi.org/10.18632/oncotarget.24824 |
Ejemplares similares
-
Androgen suppresses testicular cancer cell growth in vitro and in vivo
por: Nakagawa, Hideo, et al.
Publicado: (2016) -
Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer
por: Ueda, Takashi, et al.
Publicado: (2021) -
Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
por: Narukawa, Tsukasa, et al.
Publicado: (2020) -
A big data-based prediction model for prostate cancer incidence in Japanese men
por: Kato, Mineyuki, et al.
Publicado: (2023) -
Usefulness of a novel device to divide core needle biopsy specimens in a spatially matched fashion
por: Shiraishi, Takumi, et al.
Publicado: (2020)